Targeting the ubiquinol-reduction (Qi) site of the mitochondrial cytochrome bc1 complex for the development of next generation quinolone antimalarials
Amporndanai, K., O'Neill, P.M., Hong, W.D., Amewu, R.K., Pidathala, C., Berry, N., Biangini, G.A., Leung, S.C., Hasnain, S.S., Antonyuk, S.V.To be published.